145 related articles for article (PubMed ID: 38895337)
1. Frontotemporal dementia-like disease progression elicited by seeded aggregation and spread of FUS.
Vazquez-Sanchez S; Tilkin B; Gasset-Rosa F; Zhang S; Piol D; McAlonis-Downes M; Artates J; Govea-Perez N; Verresen Y; Guo L; Cleveland DW; Shorter J; Da Cruz S
bioRxiv; 2024 Jun; ():. PubMed ID: 38895337
[TBL] [Abstract][Full Text] [Related]
2. Frontotemporal dementia-like disease progression elicited by seeded aggregation and spread of FUS.
Vazquez-Sanchez S; Tilkin B; Gasset-Rosa F; Zhang S; Piol D; McAlonis-Downes M; Artates J; Govea-Perez N; Verresen Y; Guo L; Cleveland DW; Shorter J; Da Cruz S
Mol Neurodegener; 2024 Jun; 19(1):46. PubMed ID: 38862967
[TBL] [Abstract][Full Text] [Related]
3. Abl kinase-mediated FUS Tyr526 phosphorylation alters nucleocytoplasmic FUS localization in FTLD-FUS.
Motaln H; Čerček U; Yamoah A; Tripathi P; Aronica E; Goswami A; Rogelj B
Brain; 2023 Oct; 146(10):4088-4104. PubMed ID: 37071594
[TBL] [Abstract][Full Text] [Related]
4. RNA-binding proteins with prion-like domains in ALS and FTLD-U.
Gitler AD; Shorter J
Prion; 2011; 5(3):179-87. PubMed ID: 21847013
[TBL] [Abstract][Full Text] [Related]
5. Transportin 1 colocalization with Fused in Sarcoma (FUS) inclusions is not characteristic for amyotrophic lateral sclerosis-FUS confirming disrupted nuclear import of mutant FUS and distinguishing it from frontotemporal lobar degeneration with FUS inclusions.
Troakes C; Hortobágyi T; Vance C; Al-Sarraj S; Rogelj B; Shaw CE
Neuropathol Appl Neurobiol; 2013 Aug; 39(5):553-61. PubMed ID: 22934812
[TBL] [Abstract][Full Text] [Related]
6. Conjoint pathologic cascades mediated by ALS/FTLD-U linked RNA-binding proteins TDP-43 and FUS.
Ito D; Suzuki N
Neurology; 2011 Oct; 77(17):1636-43. PubMed ID: 21956718
[TBL] [Abstract][Full Text] [Related]
7. Molecular determinants and genetic modifiers of aggregation and toxicity for the ALS disease protein FUS/TLS.
Sun Z; Diaz Z; Fang X; Hart MP; Chesi A; Shorter J; Gitler AD
PLoS Biol; 2011 Apr; 9(4):e1000614. PubMed ID: 21541367
[TBL] [Abstract][Full Text] [Related]
8. Mislocated FUS is sufficient for gain-of-toxic-function amyotrophic lateral sclerosis phenotypes in mice.
Shiihashi G; Ito D; Yagi T; Nihei Y; Ebine T; Suzuki N
Brain; 2016 Sep; 139(Pt 9):2380-94. PubMed ID: 27368346
[TBL] [Abstract][Full Text] [Related]
9. Expression of Fused in sarcoma mutations in mice recapitulates the neuropathology of FUS proteinopathies and provides insight into disease pathogenesis.
Verbeeck C; Deng Q; Dejesus-Hernandez M; Taylor G; Ceballos-Diaz C; Kocerha J; Golde T; Das P; Rademakers R; Dickson DW; Kukar T
Mol Neurodegener; 2012 Oct; 7():53. PubMed ID: 23046583
[TBL] [Abstract][Full Text] [Related]
10. Frontotemporal lobar degeneration and amyotrophic lateral sclerosis: molecular similarities and differences.
Neumann M
Rev Neurol (Paris); 2013 Oct; 169(10):793-8. PubMed ID: 24011641
[TBL] [Abstract][Full Text] [Related]
11. The Role of Post-Translational Modifications on Prion-Like Aggregation and Liquid-Phase Separation of FUS.
Rhoads SN; Monahan ZT; Yee DS; Shewmaker FP
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29547565
[TBL] [Abstract][Full Text] [Related]
12. RNA-binding ability of FUS regulates neurodegeneration, cytoplasmic mislocalization and incorporation into stress granules associated with FUS carrying ALS-linked mutations.
Daigle JG; Lanson NA; Smith RB; Casci I; Maltare A; Monaghan J; Nichols CD; Kryndushkin D; Shewmaker F; Pandey UB
Hum Mol Genet; 2013 Mar; 22(6):1193-205. PubMed ID: 23257289
[TBL] [Abstract][Full Text] [Related]
13. FUS transgenic rats develop the phenotypes of amyotrophic lateral sclerosis and frontotemporal lobar degeneration.
Huang C; Zhou H; Tong J; Chen H; Liu YJ; Wang D; Wei X; Xia XG
PLoS Genet; 2011 Mar; 7(3):e1002011. PubMed ID: 21408206
[TBL] [Abstract][Full Text] [Related]
14. Cytoplasmic aggregation of mutant FUS causes multistep RNA splicing perturbations in the course of motor neuron pathology.
Rezvykh AP; Ustyugov AA; Chaprov KD; Teterina EV; Nebogatikov VO; Spasskaya DS; Evgen'ev MB; Morozov AV; Funikov SY
Nucleic Acids Res; 2023 Jun; 51(11):5810-5830. PubMed ID: 37115004
[TBL] [Abstract][Full Text] [Related]
15. Physiological functions and pathobiology of TDP-43 and FUS/TLS proteins.
Ratti A; Buratti E
J Neurochem; 2016 Aug; 138 Suppl 1():95-111. PubMed ID: 27015757
[TBL] [Abstract][Full Text] [Related]
16. Wild-type FUS corrects ALS-like disease induced by cytoplasmic mutant FUS through autoregulation.
Sanjuan-Ruiz I; Govea-Perez N; McAlonis-Downes M; Dieterle S; Megat S; Dirrig-Grosch S; Picchiarelli G; Piol D; Zhu Q; Myers B; Lee CZ; Cleveland DW; Lagier-Tourenne C; Da Cruz S; Dupuis L
Mol Neurodegener; 2021 Sep; 16(1):61. PubMed ID: 34488813
[TBL] [Abstract][Full Text] [Related]
17. FUS is phosphorylated by DNA-PK and accumulates in the cytoplasm after DNA damage.
Deng Q; Holler CJ; Taylor G; Hudson KF; Watkins W; Gearing M; Ito D; Murray ME; Dickson DW; Seyfried NT; Kukar T
J Neurosci; 2014 Jun; 34(23):7802-13. PubMed ID: 24899704
[TBL] [Abstract][Full Text] [Related]
18. Implications of the prion-related Q/N domains in TDP-43 and FUS.
Udan M; Baloh RH
Prion; 2011; 5(1):1-5. PubMed ID: 21135580
[TBL] [Abstract][Full Text] [Related]
19. ALS/FTLD-Linked Mutations in FUS Glycine Residues Cause Accelerated Gelation and Reduced Interactions with Wild-Type FUS.
Rhine K; Makurath MA; Liu J; Skanchy S; Lopez C; Catalan KF; Ma Y; Fare CM; Shorter J; Ha T; Chemla YR; Myong S
Mol Cell; 2020 Nov; 80(4):666-681.e8. PubMed ID: 33159856
[TBL] [Abstract][Full Text] [Related]
20. "STRESSED OUT": The role of FUS and TDP-43 in amyotrophic lateral sclerosis.
Aksoy YA; Deng W; Stoddart J; Chung R; Guillemin G; Cole NJ; Neely GG; Hesselson D
Int J Biochem Cell Biol; 2020 Sep; 126():105821. PubMed ID: 32758633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
